334
Participants
Start Date
January 20, 2023
Primary Completion Date
January 19, 2024
Study Completion Date
January 19, 2024
Tirbanibulin 2.5 mg ointment
Participants will apply tirbanibulin 2.5 mg ointment topically for 5 consecutive days over 25 square centimeters (cm\^2) of the face or scalp.
Almirall Investigational Site 1, Cagliari
Almirall Investigational Site 2, Catania
Almirall Investigational Site 3, Napoli
Almirall Investigational Site 4, Pisa
Almirall Investigational Site 5, Rimini
Almirall Investigational Site 6, Torino
Almirall Investigational Site 7, Trieste
Almirall Investigational Site 1, Alcorcón
Almirall Investigational Site 2, Alicante
Almirall Investigational Site 3, Badalona
Almirall Investigational Site 4, Barcelona
Almirall Investigational Site 5, Barcelona
Almirall Investigational Site 6, Barcelona
Almirall Investigational Site 7, Barcelona
Almirall Investigational Site 8, Bilbao
Almirall Investigational Site 9, Córdoba
Almirall Investigational Site 10, Fuenlabrada
Almirall Investigational Site 11, Granada
Almirall Investigational Site 12, Madrid
Almirall Investigational Site 13, Madrid
Almirall Investigational Site 14, Madrid
Almirall Investigational Site 15, Madrid
Almirall Investigational Site 16, Majadahonda
Almirall Investigational Site 17, Málaga
Almirall Investigational Site 18, Palma
Almirall Investigational Site 19, Pontevedra
Almirall Investigational Site 20, Sabadell
Almirall Investigational Site 21, Salamanca
Almirall Investigational Site 22, Santa Cruz de Tenerife
Almirall Investigational Site 23, Seville
Almirall Investigational Site 24, Seville
Almirall Investigational Site 25, Valencia
Almirall Investigational Site 26, Valencia
Almirall Investigational Site 27, Valencia
Almirall Investigational Site 28, Vigo
Almirall Investigational Site 29, Zaragoza
Almirall Investigational Site 30, Zaragoza
Lead Sponsor
Almirall, S.A.
INDUSTRY